Algernon Pharmaceuticals (XTER:BTI) Days Payable : 0.00 (As of May. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Days Payable?

Algernon Pharmaceuticals's average Accounts Payable for the three months ended in May. 2024 was €1.69 Mil. Algernon Pharmaceuticals's Cost of Goods Sold for the three months ended in May. 2024 was €0.00 Mil.

The historical rank and industry rank for Algernon Pharmaceuticals's Days Payable or its related term are showing as below:

XTER:BTI's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 135.18
* Ranked among companies with meaningful Days Payable only.

Algernon Pharmaceuticals's Days Payable stayed the same from May. 2023 (0.00) to May. 2024 (0.00). stayed the same

Algernon Pharmaceuticals Days Payable Historical Data

The historical data trend for Algernon Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Days Payable Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Days Payable

Get a 7-Day Free Trial

Algernon Pharmaceuticals Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Algernon Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Algernon Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algernon Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's Days Payable falls into.

Algernon Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Algernon Pharmaceuticals's Days Payable for the fiscal year that ended in Aug. 2023 is calculated as

	Days Payable (A: Aug. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Aug. 2022 )	+	Accounts Payable (A: Aug. 2023 ))	/	count )	/	Cost of Goods Sold (A: Aug. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Algernon Pharmaceuticals's Days Payable for the quarter that ended in May. 2024 is calculated as:

	Days Payable (Q: May. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Feb. 2024 )	+	Accounts Payable (Q: May. 2024 ))	/	count )	/	Cost of Goods Sold (Q: May. 2024 )	*	Days in Period
=	( (2.181	+	1.191)	/	2 )	/	0	*	365 / 4
=	1.686					/	0	*	365 / 4
=	N/A

Algernon Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XTER:BTI) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

AGNPF:USA AGW0:Germany AGN:Canada

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.